Onconic Therapeutics Inc

476060

Company Profile

  • Business description

    Onconic Therapeutics Inc is a company that researches and develops new drugs for gastrointestinal diseases and anticancers, which have large unmet medical needs. Its pipeline products are Zataprazan(OCN-101) and OCN-201.

  • Contact

    12 Teheran-ro 26-gil
    11th floor, Jeil Vision Tower
    Gangnam-gu
    Seoul06236
    KOR

    T: +82 234540780

    http://www.onconic.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    30

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,387.8018.500.22%
CAC 407,696.9231.01-0.40%
DAX 4023,249.6594.89-0.41%
Dow JONES (US)40,829.00389.83-0.95%
FTSE 1008,597.421.070.01%
HKSE22,867.59204.880.90%
NASDAQ17,689.66154.58-0.87%
Nikkei 22536,813.7816.91-0.05%
NZX 50 Index12,450.9129.820.24%
S&P 5005,606.9143.47-0.77%
S&P/ASX 2008,170.3018.900.23%
SSE Composite Index3,337.1020.980.63%

Market Movers